:: CLDF ::

Home | Contact Us | Bookmark

ALCOHOL LIVER DISEASE

PEDIATRIC LIVER DISEASE

Embassy of Education

Publications Webcasts Abstract Library Committee Members

MASH Single Disease Content

Publications


	CLDF Payer Coalition Practicum on Metabolic Dysfunction-Associated Steatohepatitis

	The use of current knowledge and non-invasive testing modalities for predicting at-risk non-alcoholic steatohepatitis and assessing fibrosis

Webcast Library


	Innovations in the Management of MASH Nadege Gunn, MD, CPI, DABOM		Educational Webcast

	Advances in Non-Invasive Assessment and Management of MASLD Rohit Loomba, MD, MHSc		Educational Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from AASLD Nancy Reau, MD, Joseph Ahn, MD & Ann Moore, NP		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from ACG Nadege Gunn, MD, CPI, Marcelo Kulgelmas, MD & Christina Hanson, FNP-C		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from EASL Kimberly Brown, MD, Sunit Janardhan, MD, PhD & Patrick Horne, MSN, ARNP		Accredited Webcast

	Expert Perspectives Post Conference Highlights on MASLD/MASH from DDW Rohit Loomba, MD, Nadege Gunn, MD, CPI & HoChong Gilles, DNP		Accredited Webcast

	CLDF Conversations: New Therapies in MASH & Comprehensive Care Hosted by Nadege Gunn, MD, with Special Guest Sujit Janardhan, MD, PhD		Educational Webcast

	Metabolic-Associated Steatotic Liver Disease: Positioning New and Emerging Therapies with Nancy Reau, MD, Kimberly Brown, MD, and Steven Flamm, MD.		Educational Webcast

	Key Take Aways-Major Advancements In The Management of MASH with Parvez, Mantry, MD		Educational Webcast

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 IU GI & Hepatology Update Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 Liver Connect Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 GALA Dallas Conference		Symposium Vignettes

	Major Advancement in MASH Management Presented by the MASH Alliance at the 2024 Advancing GI Patient Care Conference		Symposium Vignettes

	Liver Connect 2023		Educational Webcast

	NASH Connect 2023		Educational Webcast

	NAFLD/NASH		Educational Webcast

	Advances in NAFLD/NASH		Educational Webcast

	New Advances in NASH Diagnostics and Prognostics		Educational Webcast

	New Advances in NASH Diagnostics and Prognostics		Educational Webcast

	Pearls and Pitfalls update on emerging therapies in NASH		Educational Webcast

Abstract Library

1.	Bidirectional shifts in Pm20d1 expression impact thermogenesis and metabolism.
	Simoes, Marcela R (MR);Gallo-Ferraz, Ana L (AL);Bombassaro, Bruna (B);Valdivieso-Rivera, Fernando (F);Nogueira, Guilherme A S (GAS);Monfort-Pires, Milena (M);da Cruz, Marcos Vinicius (MV);Zanesco, Ariane M (AM);Fernanda-Oliveira, Nayra (N);Silveira, Leonardo Reis (LR);Castilho, Roger F (RF);Sponton, Carlos H (CH);Velloso, Licio A (LA);

2.	Gut-Microbiome and Nutritional Analysis Reveals Food Intake as a Key Factor in the Incidence and Prevention of Colon Polyps: A Cross-Sectional Study.
	Ma, Chuanmin (C);Zhang, Mingbao (M);Chen, Binbin (B);Liu, Ming (M);Jiang, Huiyu (H);Li, Jiaorong (J);Song, Xintong (X);Wei, Xiangrui (X);Wei, Zhixing (Z);Liu, Jingyao (J);Guan, Hengyun (H);Zhou, Jun (J);Liu, Hui (H);

3.	Association between serum albumin to creatinine ratio and non-alcoholic fatty liver disease: a longitudinal cohort study in non-obese Chinese individuals.
	Wu, Weitao (W);Wu, Donghai (D);Chen, Fanglan (F);Ding, Shihua (S);Ying, Ying (Y);Sun, Dayong (D);Hu, Haofei (H);

4.	Immunosuppression variably impacts outcomes for patients hospitalized with COVID-19: A retrospective cohort study.
	Guggilla, Vijeeth (V);Pacheco, Jennifer A (JA);Carvalho, Alexandre M (AM);Whitmer, Grant R (GR);Pawlowski, Anna E (AE);Johnson, Jodi L (JL);Gao, Catherine A (CA);Achenbach, Chad J (CJ);Walunas, Theresa L (TL);

5.	The role of link workers in weight management for people with severe mental illness: a qualitative study.
	Imran, Rija (R);Kenny, Alexandra (A);Wong, Geoffrey (G);Lee, Charlotte (C);

6.	Implementation outcomes of a community dialogue intervention to improve primary care performance in a Ugandan rural health sub-district.
	Besigye, Innocent (I);Mash, Robert (R);

7.	Prevalence of liver disorders in children and adolescents with type 1 diabetes mellitus.
	Anicic, Mirna Natalija (MN);Dumic, Katja (K);Kolega Mrkic, Lucija (L);Spehar Uroic, Anita (A);Krnic, Nevena (N);Zidanic, Martina (M);Coric, Marijana (M);Vukovic, Jurica (J);

8.	Exploring hepatic stellate cell-driven fibrosis: therapeutic advances and future perspectives.
	Singh, Alka (A);Akhtar, Ansab (A);Shukla, Prashant (P);

9.	Effect of lifestyle changes on liver enzymes, triglycerides, sex hormones, and daytime sleepiness in polycystic ovarian syndrome women with obstructive sleep apnea and fatty liver - a randomized controlled trial.
	Ali Ismail, Ali Mohamed (AM);Mousa, Nehad Mohamed AbdElnabi (NMA);Elgendy, Sami Kamal Mohamed (SKM);Al-Emrany, Asmaa M (AM);Saber, Orchid Saber AbdelFadil (OSA);Elhakk, Sahar Mohamed Adel (SMA);Mohamed, Dina (D);Ghaleb, Heba Ahmed Mousa (HAM);

10.	Biomarker discovery in NAFLD: insights from metabolomics and vote counting meta-analysis.
	Mudgal, Pallavi (P);Kumar Gupta, Sonu (S);Malik, Sunny (S);Nith, Rinkal B (RB);Kumar, Sunil (S);K, Rahul (R);Chaturvedi, Kartikey (K);Kumar, Yashwant (Y);

11.	The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review.
	Vachliotis, Ilias D (ID);Polyzos, Stergios A (SA);

12.	The prevalence and correlates of advanced fibrosis in patients with and without diabetes mellitus and metabolic dysfunction-associated steatotic liver disease: A cross-sectional study.
	Muzurovi?, Emir (E);Topi?, Goran (G);Todorovi?, Nevena (N);Rizzo, Manfredi (M);Ze?evi?, Ksenija (K);

13.	Adding salt to foods increases the risk of metabolic dysfunction-associated steatotic liver disease.
	Chen, Han (H);Zhang, Xujun (X);Lin, Shujuan (S);Wu, Qiong (Q);

14.	Molecular spectroscopy of blood plasma differentiates metabolic dysfunction-associated steatohepatitis from steatosis.
	Nováková, Barbora (B);Vrt?lka, Ond?ej (O);Králová, Kate?ina (K);Habartová, Lucie (L);Šmíd, Václav (V);Dvo?ák, Karel (K);Petrtýl, Jaromír (J);Žížalová, Kate?ina (K);St?íteský, Jan (J);Vítek, Libor (L);Lení?ek, Martin (M);Setni?ka, Vladimír (V);Br?ha, Radan (R);

15.	Palmitate enhances MSC immunomodulation of human macrophages via the ceramide/CCL2 axis in vitro.
	Tunstead, Courteney (C);Bitterlich, Laura M (LM);Ankrum, James A (JA);Hogan, Andrew E (AE);English, Karen (K);

16.	Adolescents with Low Body Mass Index Are More Vulnerable to Pediatric Nondisplaced Femoral Neck Fractures.
	Lee, Jong Wha (JW);Cho, Jae Ho (JH);Kim, Tae Hun (TH);

17.	Non-linear association between metabolic score for insulin resistance and nonalcoholic fatty liver disease: analysis of US National health and nutrition examination survey data, 2017-2020.
	Wang, Shanshan (S);Li, Ping (P);Guo, Zhenhong (Z);Rao, Xiaojuan (X);

18.	Effects of five cannabis oils with different CBD: THC ratios and terpenes on hypertension, dyslipidemia, hepatic steatosis, oxidative stress, and CB1 receptor in an experimental model.
	Degrave, Valentina (V);Vega Joubert, Michelle Berenice (MB);Filippa, Camila (C);Ingaramo, Paola (P);Torregiani, Lucía (L);Caro, Yamile Soledad (YS);De Zan, María Mercedes (MM);D'Alessandro, María Eugenia (ME);Oliva, María Eugenia (ME);

19.	Serum metabolites characterize hepatic phenotypes and reveal shared pathways: results from population-based imaging.
	Maushagen, Juliane (J);Nattenmüller, Johanna (J);von Krüchten, Ricarda (R);Thorand, Barbara (B);Peters, Annette (A);Rathmann, Wolfgang (W);Adamski, Jerzy (J);Schlett, Christopher L (CL);Bamberg, Fabian (F);Wang-Sattler, Rui (R);Rospleszcz, Susanne (S);

20.	Machine learning survival models for Non-alcoholic fatty liver disease based on a health checkup cohort.
	Zhang, Hongyu (H);Zhang, Li (L);Li, Na (N);Zhang, Yongsheng (Y);Zhang, Xiaowen (X);Wang, Dawei (D);

21.	Pulse Oximetry Desaturation in the Postoperative Recovery Room in Patients with Obesity and Diabetes Using GLP-1 Agonists: A Retrospective Observational Study.
	Skidmore, Kimberly L (KL);Le, Hong (H);Segredo, Veronica (V);Boullion, Jolie A (JA);Daniel, Charles P (CP);Smith, Van (V);Varrassi, Giustino (G);Shekoohi, Sahar (S);Kaye, Alan D (AD);

22.	Postoperative Body Image Perceptions and Mental Health Outcomes in Adults Undergoing Bariatric Surgery: A Cross-Sectional Study.
	Alamri, Mousa A (MA);Alharbi, Yasir A (YA);Alharbi, Hatem H (HH);Jumah, Ali A (AA);

23.	Exploring midwifery competence and confidence based on midwives' experiences and stakeholders' insights in Kenya: a descriptive phenomenological approach.
	Tallam, Edna (E);Kaura, Doreen (D);Mash, Robert (R);

24.	Fenofibrate in Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysis.
	Kumar, Manoj (M);Awasthi, Avivar (A);Dutta, Deep (D);Joshi, Ameya (A);Sharma, Meha (M);

25.	Trends and demographic disparities in heart failure mortality rates in non-alcoholic fatty liver disease: a population-based retrospective study in the United States from 1999 to 2020.
	Plunkett, Ryan D (RD);Ahmed, Faizan (F);Thomas, Alexander (A);Rotramel, Hayden (H);Mirza, Tehmasp Rehman (TR);Philip, Nicholas (N);Rojulpote, Chaitanya (C);Mikhalkova, Deana (D);Qureshi, Kamran (K);Lin, Chien-Jung (CJ);

HEPATITIS

CLD HEALTH OUTCOMES

CIRRHOSIS

Cirrhosis
HE
HRS
Thrombocytopenia

MASH

Slide Library
Publications
Webcasts
Abstract Library Committee Members

CHOLESTATIC

HCC

Slide Library
Publications
Webcasts
Algorithm
Abstract Library Committee Members

ALCOHOL LIVER DISEASE

Recorded Educational Webinar

PEDIATRIC LIVER DISEASE

Webcasts
Slide Library
Abstract Library

About CLDF

Board of Trustees
Board of Advisors/Faculty
CLDF Committees
2025 GI Fellow Board of Advisors

Other Resources

Journal Abstracts

Follow us

Youtube

LiverQ

The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2025 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.